D. E. Shaw & Co., Inc. - NABRIVA THERAPEUTICS PLC ownership

Back to all holdings Add to watchlist

NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105.

Links
Filings
Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of NABRIVA THERAPEUTICS PLC
ValueSharesWeighting
Q3 2019$40,000
-86.5%
19,840
-83.6%
0.00%–
Q1 2019$296,000
+322.9%
121,245
+369.4%
0.00%–
Q3 2018$70,000
-90.1%
25,831
-70.0%
0.00%
-100.0%
Q3 2017$706,000–86,144–0.00%–
 Download
Other shareholders
NABRIVA THERAPEUTICS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 191,028$462,0000.08%
Sterling Investment Advisors, Ltd. 5,000$12,0000.00%
IFP Advisors, Inc 0$00.00%
View complete list of NABRIVA THERAPEUTICS PLC shareholders